Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
Completion of the demerger of Haleon and share consolidation of GSK
ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Company is investing more than €100 million in the expansion of the Halle site
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
Subscribe To Our Newsletter & Stay Updated
